About the Product

Description


Atorable 20 F Tablet containing Atorvastatin and Fenofibrate is used for the management of high cholesterol and triglyceride levels. It helps improve lipid balance and supports cardiovascular health.

Atorvastatin works by reducing bad cholesterol and improving good cholesterol levels, while Fenofibrate helps lower triglycerides and supports healthy fat metabolism.

The tablet is widely prescribed in cardiac and general medicine practice for long-term lipid management therapy, leading to consistent prescription demand.

With increasing prevalence of lifestyle-related cardiovascular disorders and dyslipidemia, this product offers strong business potential for retailers and distributors. Its dual lipid-lowering action, broad clinical relevance, and steady market demand make it a reliable product for growth in the cardiac care segment.

Some patients may experience headache, nausea, abdominal discomfort, constipation, muscle pain, or weakness. Rarely, liver dysfunction, pancreatitis, or severe muscle-related complications such as myopathy or rhabdomyolysis may occur and require medical attention.

Atorable 20 F Tablet is indicated for mixed dyslipidemia, high cholesterol, elevated triglycerides, and prevention of cardiovascular complications associated with abnormal lipid levels. It helps reduce LDL cholesterol and triglycerides while improving HDL cholesterol levels.

This medicine should be used under medical supervision along with a healthy diet and regular exercise. Regular monitoring of liver function and lipid profile is recommended during treatment. Use cautiously in patients with liver, kidney, or gallbladder disorders.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Atorable 20 F Tablet in the PCD pharma franchise market?

Atorable 20 F Tablet, containing Atorvastatin 20mg and Fenofibrate 160mg, has strong demand in the cardiometabolic and lipid management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cholesterol and heart health portfolios.

Why should medical distributors include Atorable 20 F Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for combination lipid-lowering therapy used in high cholesterol, hypertriglyceridemia, mixed dyslipidemia, and cardiovascular risk management. Atorvastatin reduces LDL cholesterol while Fenofibrate targets triglycerides, strengthening a comprehensive cardiac care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Atorable 20 F Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Atorable 20 F Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Atorable 20 F Tablet distribution?

Wholesalers and medical agencies benefit from strong chronic cardiovascular prescription demand, long-term therapy usage, reliable supply chain support, and good margins when partnering for Atorable 20 F Tablet distribution.

How can I become a distributor or franchise partner for Atorable 20 F Tablet?

Medical distributors, stockists, and wholesalers interested in Atorable 20 F Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.